Skip to main content

Table 2 Demographics and physical characteristics at baseline

From: A pilot study on the use of interferon beta-1a in early Alzheimer’s disease subjects

Characteristic Placeboa Interferon beta 1aa Pvalue
Age at informed consent (yrs) 64.57 ± 6.4 63.0 ± 9.07 0.57
Height (cm) 165.11 ± 7.52 163.0 ± 9.01 0.42
Weight (kg) 71.59 ± 9.92 68.17 ± 10.04 0.27
Systolic pressure (mmHg) 131.05 ± 7.56 164.74 ± 18.26 0.31
Diastolic pressure (mmHg) 79.47 ± 6.64 116.26 ± 19.2. 0.26
Pulse rate (bpm) 70.94 ± 11.88 71.56 ± 6.97 0.86
Sexb 8 (male); 11 (female) 8 (male); 15 (female) 0.62
Concomitant age-related diseases different from AD 14 (yes); 4 (no) 14 (yes); 8 (no) 0.94
  1. aValues are expressed as means ± SD. bSex values are reported as absolute values.